Paper22085528
miR-124 suppresses multiple steps of breast cancer metastasis by targeting a cohort of pro-metastatic genes in vitro.
Lv XB and 7 others. Chin J Cancer, 2011. Cited by 68 papers, by iCite.
Cite this record
ConductScience Library. miR-124 suppresses multiple steps of breast cancer metastasis by targeting a cohort of pro-metastatic genes in vitro. Papers, record 22085528. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/22085528
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- miR-124 suppresses multiple steps of breast cancer metastasis by targeting a cohort of pro-metastatic genes in vitro.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Breast Neoplasms | Major topic |
| MicroRNAs | Major topic |
| Neoplasm Metastasis | Major topic |
| Anoikis | |
| Cell Adhesion | |
| Cell Line, Tumor | |
| Cell Movement | |
| Connective Tissue Growth Factor | |
| DNA Methylation | |
| Down-Regulation | |
| Female | |
| Gene Expression Regulation, Neoplastic | |
| Humans | |
| rho GTP-Binding Proteins | |
| rho-Associated Kinases |
Source PubMed
References34
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 18083101 | let-7 regulates self renewal and tumorigenicity of breast cancer cells. | Cell | 2007 | https://conductscience.org/library/papers/18083101 | PubMed |
| 2 | 19435910 | Epigenetic silencing of the tumor suppressor microRNA Hsa-miR-124a regulates CDK6 expression and confers a poor prognosis in acute lymphoblastic leukemia. | Cancer Res | 2009 | https://conductscience.org/library/papers/19435910 | PubMed |
| 3 | 20085706 | Transcriptional control of gene expression by microRNAs. | Cell | 2010 | https://conductscience.org/library/papers/20085706 | PubMed |
| 4 | 21196113 | miR-124a is frequently down-regulated in glioblastoma and is involved in migration and invasion. | Eur J Cancer | 2011 | https://conductscience.org/library/papers/21196113 | PubMed |
| 5 | 20565758 | Integrin expression profiling identifies integrin alpha5 and beta1 as prognostic factors in early stage non-small cell lung cancer. | Mol Cancer | 2010 | https://conductscience.org/library/papers/20565758 | PubMed |
| 6 | 18607543 | Regulation of cyclin dependent kinase 6 by microRNA 124 in medulloblastoma. | J Neurooncol | 2008 | https://conductscience.org/library/papers/18607543 | PubMed |
| 7 | 14662653 | Expression and molecular characterization of alternative transcripts of the ARHGEF5/TIM oncogene specific for human breast cancer. | Hum Mol Genet | 2004 | https://conductscience.org/library/papers/14662653 | PubMed |
| 8 | 12796779 | Imprinted microRNA genes transcribed antisense to a reciprocally imprinted retrotransposon-like gene. | Nat Genet | 2003 | https://conductscience.org/library/papers/12796779 | PubMed |
| 9 | 17951630 | Connective tissue growth factor is overexpressed in esophageal squamous cell carcinoma and promotes tumorigenicity through beta-catenin-T-cell factor/Lef signaling. | J Biol Chem | 2007 | https://conductscience.org/library/papers/17951630 | PubMed |
| 10 | 19843643 | miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma. | Carcinogenesis | 2010 | https://conductscience.org/library/papers/19843643 | PubMed |
| 11 | 19887601 | Beta1-integrin circumvents the antiproliferative effects of trastuzumab in human epidermal growth factor receptor-2-positive breast cancer. | Cancer Res | 2009 | https://conductscience.org/library/papers/19887601 | PubMed |
| 12 | 19524507 | A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis. | Cell | 2009 | https://conductscience.org/library/papers/19524507 | PubMed |
| 13 | 17110329 | Cancer metastasis: building a framework. | Cell | 2006 | https://conductscience.org/library/papers/17110329 | PubMed |
| 14 | 19001122 | Induction of cell retraction by the combined actions of Abl-CrkII and Rho-ROCK1 signaling. | J Cell Biol | 2008 | https://conductscience.org/library/papers/19001122 | PubMed |
| 15 | 15806104 | Combinatorial microRNA target predictions. | Nat Genet | 2005 | https://conductscience.org/library/papers/15806104 | PubMed |
| 16 | 16568096 | Involvement of the Rho/Rac family member RhoG in caveolar endocytosis. | Oncogene | 2006 | https://conductscience.org/library/papers/16568096 | PubMed |
| 17 | 20395298 | Damaged DNA-binding protein 1 (DDB1) interacts with Cdh1 and modulates the function of APC/CCdh1. | J Biol Chem | 2010 | https://conductscience.org/library/papers/20395298 | PubMed |
| 18 | 21455569 | Expression of connective tissue growth factor (CTGF/CCN2) in breast cancer cells is associated with increased migration and angiogenesis. | Int J Oncol | 2011 | https://conductscience.org/library/papers/21455569 | PubMed |
| 19 | 16491070 | Epigenetic gene silencing in cancer - a mechanism for early oncogenic pathway addiction? | Nat Rev Cancer | 2006 | https://conductscience.org/library/papers/16491070 | PubMed |
| 20 | 20064505 | Roles of lysophosphatidic acid and the Rho-associated kinase pathway in the migration of dental pulp cells. | Exp Cell Res | 2010 | https://conductscience.org/library/papers/20064505 | PubMed |
Cited by43
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 68 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42712663 | MircoRNAs as regulators of regulated cell death in cancer progression: a focus on ferroptosis, anoikis and pyroptosis. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42712663 | PubMed |
| 40943185 | In Silico Identification of circPIM1/miR-16-5p/miR-195-5p/PIM1 Feed-Forward Loop in Recurrent Grade 2 Meningioma. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40943185 | PubMed |
| 40115961 | Comparative epigenomics to clinical trials in human breast cancer and canine mammary tumor. | Anim Cells Syst (Seoul) | 2025 | https://conductscience.org/library/papers/40115961 | PubMed |
| 37537585 | Anoikis resistance--protagonists of breast cancer cells survive and metastasize after ECM detachment. | Cell Commun Signal | 2023 | https://conductscience.org/library/papers/37537585 | PubMed |
| 37035739 | Exosomal miRNAs as novel avenues for breast cancer treatment. | Front Genet | 2023 | https://conductscience.org/library/papers/37035739 | PubMed |
| 35910021 | Predicting Multiple Types of Associations Between miRNAs and Diseases Based on Graph Regularized Weighted Tensor Decomposition. | Front Bioeng Biotechnol | 2022 | https://conductscience.org/library/papers/35910021 | PubMed |
| 35008529 | miR-205-5p Downregulation and ZEB1 Upregulation Characterize the Disseminated Tumor Cells in Patients with Invasive Ductal Breast Cancer. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/35008529 | PubMed |
| 34837933 | Investigation the Cytotoxicity of 5-AZA on Acute Lymphoblastic Leukemia Cell Line In Vitro and Characterization the Underlying Molecular Mechanisms of Cell Death and Motility. | Asian Pac J Cancer Prev | 2021 | https://conductscience.org/library/papers/34837933 | PubMed |
| 34072894 | Tumor Suppressive Effects of miR-124 and Its Function in Neuronal Development. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34072894 | PubMed |
| 33917233 | Exosomal microRNAs: Pleiotropic Impacts on Breast Cancer Metastasis and Their Clinical Perspectives. | Biology (Basel) | 2021 | https://conductscience.org/library/papers/33917233 | PubMed |
| 32668603 | Potential miRNAs for miRNA-Based Therapeutics in Breast Cancer. | Noncoding RNA | 2020 | https://conductscience.org/library/papers/32668603 | PubMed |
| 32450513 | CDYL2 Epigenetically Regulates MIR124 to Control NF-κB/STAT3-Dependent Breast Cancer Cell Plasticity. | iScience | 2020 | https://conductscience.org/library/papers/32450513 | PubMed |
| 31611991 | Knockdown of neuron-specific enolase suppresses the proliferation and migration of NCI-H209 cells. | Oncol Lett | 2019 | https://conductscience.org/library/papers/31611991 | PubMed |
| 31569550 | Genome-Wide Methylation Profiling in Canine Mammary Tumor Reveals miRNA Candidates Associated with Human Breast Cancer. | Cancers (Basel) | 2019 | https://conductscience.org/library/papers/31569550 | PubMed |
| 31496749 | MicroRNA-26a-5p inhibits proliferation, invasion and metastasis by repressing the expression of Wnt5a in papillary thyroid carcinoma. | Onco Targets Ther | 2019 | https://conductscience.org/library/papers/31496749 | PubMed |
| 31480319 | CNNDLP: A Method Based on Convolutional Autoencoder and Convolutional Neural Network with Adjacent Edge Attention for Predicting lncRNA-Disease Associations. | Int J Mol Sci | 2019 | https://conductscience.org/library/papers/31480319 | PubMed |
| 31467878 | Bta-miR-124a Affects Lipid Metabolism by Regulating PECR Gene. | Biomed Res Int | 2019 | https://conductscience.org/library/papers/31467878 | PubMed |
| 29552191 | MicroRNA-124-3p expression and its prospective functional pathways in hepatocellular carcinoma: A quantitative polymerase chain reaction, gene expression omnibus and bioinformatics study. | Oncol Lett | 2018 | https://conductscience.org/library/papers/29552191 | PubMed |
| 29343249 | microRNA-124 inhibits bone metastasis of breast cancer by repressing Interleukin-11. | Mol Cancer | 2018 | https://conductscience.org/library/papers/29343249 | PubMed |
| 28799567 | Identification of breast cancer mechanism based on weighted gene coexpression network analysis. | Cancer Gene Ther | 2017 | https://conductscience.org/library/papers/28799567 | PubMed |
Genes16
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/22085528
GET https://conductscience.org/api/papers/v1/22085528/references?page=2